Gemseki

Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.

Curreio is a drug discovery business utilizing structural analysis using a cryo-electron microscope. Their product provides structural analysis technology that allows observation by freezing the in-vivo structure without staining, enabling researchers to discover and analyze life-saving drugs using structural analysis-based drug discovery methods.

Cardio Intelligence creates an artificial intelligence (AI) automatic diagnosis system with accuracy comparable to that of specialists, assisting medical professionals involved in the treatment and prevention of heart disease, and working to reduce the number of patients worldwide who have difficulty obtaining medical care. It supports medical professionals involved in treatment and prevention, and it works to reduce the number of patients who have difficulty accessing medical care all over the world.